Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 12 professional analysts, the 12-month price target for Rhythm Pharmaceuticals stock ranges from a low of $65 to a high of $94. The average analyst price target of $76.75 forecasts a 12.69% increase in the stock price over the next year.

Price Target: $76.75 (+12.69%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$65	$76.75	$75	$94
Change	-4.57%	+12.69%	+10.12%	+38.01%

Analyst Ratings

The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	6	6	6	7	8	8
Buy	3	3	3	4	4	4
Hold	1	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Paul Matteis Stifel	Stifel	Strong Buy Maintains $78 → $94	Strong Buy	Maintains	$78 → $94	+38.01%	May 29, 2025
Joseph Stringer Needham	Needham	Strong Buy Maintains $66 → $72	Strong Buy	Maintains	$66 → $72	+5.71%	May 7, 2025
Tazeen Ahmad B of A Securities	B of A Securities	Strong Buy Maintains $63 → $68	Strong Buy	Maintains	$63 → $68	-0.16%	Apr 10, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $70 → $80	Strong Buy	Reiterates	$70 → $80	+17.46%	Apr 8, 2025
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $81 → $92	Strong Buy	Maintains	$81 → $92	+35.08%	Apr 8, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

179.00M

Increased by 37.56%

from 130.13M

Revenue Next Year

313.24M

Increased by 74.99%

from 179.00M

EPS This Year

-2.78

from -4.34

EPS Next Year

-1.51

from -2.78

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	3.15M	23.64M	77.43M	130.13M	179.00M	313.24M	563.20M
Revenue Growth	-	-	649.46%	227.56%	68.06%	37.56%	74.99%	79.80%
EPS	-3.04	-1.40	-3.47	-3.20	-4.34	-2.78	-1.51	1.86
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	36.52
No. Analysts	-	-	-	-	-	14	14	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	191.5M	420.0M	686.8M
Avg	179.0M	313.2M	563.2M
Low	166.6M	226.8M	420.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	47.1%	134.6%	119.3%
Avg	37.6%	75.0%	79.8%
Low	28.0%	26.7%	34.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.44	-0.23	3.16
Avg	-2.78	-1.51	1.86
Low	-3.09	-2.50	1.01

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.